Trial Profile
Pivotal registrational trial of ILC (Inhaled Lipid-complexed Cisplatin) for the treatment of osteosarcoma.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 May 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- Sponsors Eleison Pharmaceuticals
- 05 May 2015 New trial record